abstract |
The present invention relates to the use of a compound of formula (I) or formula (II) in the treatment of a VEGF-promoted angiogenic disease in a mammal, or said compound in the treatment of said disease in warm-blooded animals, especially humans. To a pharmaceutical formulation comprising said compound for treating said disease, and said compound for use in treating said disease. |